These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 18615357)

  • 1. Regression of cirrhosis of the liver detected by elastiometry.
    Mössner BK; Biagini M; Pedersen C; Christensen PB
    Scand J Gastroenterol; 2008; 43(11):1401-2. PubMed ID: 18615357
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of lamivudine on cirrhotic patients following chronic hepatitis B].
    Lin XF; Lin XY; Han QX; Wang JH
    Zhonghua Gan Zang Bing Za Zhi; 2002 Aug; 10(4):304. PubMed ID: 12223149
    [No Abstract]   [Full Text] [Related]  

  • 3. Changes in liver stiffness measurement during antiviral therapy in patients with chronic hepatitis B.
    Lim SG; Cho SW; Lee YC; Jeon SJ; Lee MH; Cho YJ; Kim SS; Kim YB; Seok JY; Cheong JY; Kim JH
    Hepatogastroenterology; 2011; 58(106):539-45. PubMed ID: 21661428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lamivudine and rapid regeneration of the atrophic liver in decompensated cirrhosis due to hepatitis B.
    Saito T; Shinzawa H; Watanabe H; Sugahara K; Okumoto K; Togashi H; Kawata S
    Am J Gastroenterol; 2002 Feb; 97(2):493-5. PubMed ID: 11866301
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy and safety of entecavir in patients with chronic hepatitis B and advanced hepatic fibrosis or cirrhosis.
    Schiff E; Simsek H; Lee WM; Chao YC; Sette H; Janssen HL; Han SH; Goodman Z; Yang J; Brett-Smith H; Tamez R
    Am J Gastroenterol; 2008 Nov; 103(11):2776-83. PubMed ID: 18721244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of lamivudine treatment in patients with severe acute exacerbation of hepatitis B e antigen (HBeAg)-positive chronic hepatitis B.
    Wong VW; Wong GL; Tsang SW; Hui AY; Chim AM; Yiu KK; Chan HY; Chan FK; Sung JJ; Chan HL
    Antivir Ther; 2008; 13(4):571-9. PubMed ID: 18672536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive assessment of liver fibrosis: the gap between ideal and real.
    Kim SU; Han KH; Ahn SH
    J Gastroenterol Hepatol; 2011 Jun; 26(6):937-9. PubMed ID: 21564284
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of long-term lamivudine therapy on histological outcome in chronic hepatitis B.
    De Ridder RJ; Stronkhorst A
    Gastroenterology; 2003 Oct; 125(4):1286-7; author reply 1287. PubMed ID: 14552322
    [No Abstract]   [Full Text] [Related]  

  • 9. Eight-cycle rituximab therapy resulted in complete remission in primary cutaneous marginal zone lymphoma.
    Seker M; Ustaalioğlu BB; Bilici A; Yildirim ME; Kefeli U; Barisik NO; Tamer I; Gumus M
    Leuk Res; 2010 Jul; 34(7):e160-3. PubMed ID: 20219245
    [No Abstract]   [Full Text] [Related]  

  • 10. [To enhance the diagnosis and treatment of liver fibrosis].
    Mu YP; Liu CH
    Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):561-2. PubMed ID: 23227527
    [No Abstract]   [Full Text] [Related]  

  • 11. Lamivudine treatment in patients with decompensated hepatitis B cirrhosis: for whom and when?
    Fontana RJ; Lok AS
    J Hepatol; 2000 Aug; 33(2):329-32. PubMed ID: 10952253
    [No Abstract]   [Full Text] [Related]  

  • 12. Is lamivudine a safe and effective therapy for patients with chronic hepatitis B and advanced liver disease?
    Karayiannis P; Thomas HC
    Nat Clin Pract Gastroenterol Hepatol; 2005 Mar; 2(3):138-9. PubMed ID: 16265154
    [No Abstract]   [Full Text] [Related]  

  • 13. [Emphasis on the antiviral therapy for decompensated hepatitis B-related cirrhosis].
    Fu QC; Chen CW
    Zhonghua Yi Xue Za Zhi; 2010 Jun; 90(23):1585-6. PubMed ID: 20979741
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of HBV-related cirrhosis.
    Vallet-Pichard A; Mallet V; Costentin CE; Pol S
    Expert Rev Anti Infect Ther; 2009 Jun; 7(5):527-35. PubMed ID: 19485793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic hepatitis B: back to the future with HBsAg.
    Moucari R; Lada O; Marcellin P
    Expert Rev Anti Infect Ther; 2009 Aug; 7(6):633-6. PubMed ID: 19681689
    [No Abstract]   [Full Text] [Related]  

  • 16. [Lamivudine treatment of a HBs antigen positive man with reactive arthritis].
    Borup C; Siboni A
    Ugeskr Laeger; 2008 Nov; 170(48):3940-1. PubMed ID: 19087731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of patients with decompensated hepatitis B virus associated [corrected] cirrhosis.
    Zoulim F; Radenne S; Ducerf C
    Liver Transpl; 2008 Oct; 14 Suppl 2():S1-7. PubMed ID: 18825719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoprevention of hepatocellular carcinoma in chronic hepatitis B with lamivudine?
    Lim LY; Kowdley KV
    Gastroenterology; 2005 Dec; 129(6):2120-2; discussion 2122. PubMed ID: 16344085
    [No Abstract]   [Full Text] [Related]  

  • 19. Liver transplantation in chronic hepatitis B.
    Gane E
    Med J Malaysia; 2005 Jul; 60 Suppl B():88-9. PubMed ID: 16108183
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic cirrhotic hepatitis B patients with a high incidence of hepatic decompensation after viral breakthrough with lamivudine-resistant mutants and during rescue treatment.
    Joo MK; Yeon JE; Kim JH; Jung YK; Lee SJ; Kim JH; Yim HJ; Byun KS; Park JJ; Kim JS; Bak YT
    Scand J Gastroenterol; 2008; 43(12):1514-21. PubMed ID: 18663665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.